Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum

SARS-CoV-2 and its variants continue to infect hundreds of thousands every day despite the rollout of effective vaccines. Therefore, it is essential to understand the levels of protection that these vaccines provide in the face of emerging variants. Here, we report two demographically balanced cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Bates, Timothy A., Leier, Hans C., Lyski, Zoe L., McBride, Savannah K., Coulter, Felicity J., Weinstein, Jules B., Goodman, James R., Lu, Zhengchun, Siegel, Sarah A. R., Sullivan, Peter, Strnad, Matt, Brunton, Amanda E., Lee, David X., Adey, Andrew C., Bimber, Benjamin N., O’Roak, Brian J., Curlin, Marcel E., Messer, William B., Tafesse, Fikadu G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390486/
https://www.ncbi.nlm.nih.gov/pubmed/34446720
http://dx.doi.org/10.1038/s41467-021-25479-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390486/
https://www.ncbi.nlm.nih.gov/pubmed/34446720
http://dx.doi.org/10.1038/s41467-021-25479-6

Ejemplares similares